Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (1): 88-92    DOI: 10.12891/ceog3258.2017
Original Research Previous articles | Next articles
Uterine-fundal hypoechoic mass: a possible ultrasound sign for cesarean scar pregnancy
H. Takahashi1, R. Usui1, H. Suzuki1, Y. Baba1, T. Suzuki1, T. Kuwata1, A. Ohkuchi1, S. Matsubara1, *()
1 Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: Cesarean scar pregnancy (CSP) is a life-threatening condition that requires early pregnancy termination. Its early ultrasound diagnosis is clinically important; however, previous studies focused on the CSP site itself. The present study was conducted to investigate the authors’ clinical impression that a uterine-fundal hypoechoic mass is more frequently observed in CSP. Such a finding, if confirmed, may contribute to ultrasound diagnosis of CSP. The authors also determined the relationship between the treatment strategy and outcome, with special emphasis on conditions eventually requiring uterine artery embolization (UAE). Materials and Methods: This was a case-control study of CSP, and the authors analyzed all 14 women that were treated in this single tertiary institute over a period of ten years. Control subjects consisted of all pregnant women with prior cesarean section (CS) but no CSP. Results: Patients with CSP were significantly more likely to have a hypoechoic mass than controls (42.9 vs. 15.4%, respectively; p = 0.028). On confining results to a “fundal” hypoechoic mass, only CSP(+) patients showed it (CSP vs. control: 28.6 vs. 0%, respectively; p < 0.001). Six (43%: 6/14) received UAE: four following vaginal evacuation (artificial or spontaneous), and two for bleeding after methotrexate (MTX) treatment. Conclusion: Patients with CSP more frequently had a uterine-fundal hypoechoic mass, whose detection may trigger a detailed observation of the CSP site, possibly leading to CSP diagnosis.
Key words:  Cesarean scar pregnancy      Cesarean section      Placenta accreta      Intrauterine hematoma      Subchorionic hematoma     
Published:  10 February 2017     
*Corresponding Author(s):  S. MATSUBARA     E-mail:  matsushi@jichi.ac.jp

Cite this article: 

H. Takahashi, R. Usui, H. Suzuki, Y. Baba, T. Suzuki, T. Kuwata, A. Ohkuchi, S. Matsubara. Uterine-fundal hypoechoic mass: a possible ultrasound sign for cesarean scar pregnancy. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 88-92.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3258.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I1/88

[1] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception withenhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[2] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[3] A.M. Sindiani, H.M. Rawashdeh, E.H. Alshdaifat, O.F. Altal, H. Yaseen, A.A. Alhowary. The association between repeated doses of vaginal PGE2 (Dinoprostone, Prostin®) and both maternal and neonatal outcomes among women in the north of Jordan[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 329-334.
[4] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[5] J. Huang, Z. Zhang. Spontaneous umbilical cord vascular rupture before labor for congenital defects with a live birth: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 142-143.
[6] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[7] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S. Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[8] H. Kiyak, L. S. Turkgeldi, C. Ozdemir, S. Gunkaya, K. Tolga, A. Gedikbası. Myomectomy during cesarean section: is it a redundant or a feasible procedure?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 881-887.
[9] A. Basha, Z. Falayleh, R. Jabra, S. Attili, Y. Obeidat, L. El-Khatib, A. Ala’eddien Obeidat. Cesarean section: Where are we are now? A comparative study between 1997-1998 and 2015-2016 at a tertiary teaching hospital in a developing country[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 943-947.
[10] Y. Wang, F.Y. Luo, Y.D. Xia, L. Mei, L. Xie, H.X. Liu. Clinical analysis of 211 cases of cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 948-952.
[11] G. Virdis, F. Dessole, A. Andrisani, A. Vitagliano, R. Cappadona, G. Capobianco, E. Cosmi, G. Ambrosini, S. Dessole. Cesarean scar pregnancy: a report of three cases and a critical review on the management[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 982-985.
[12] Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.
[13] M. Trisovic, O. Mladenovic, J. Bila, K. Lalić, D. Kisic Tepavcevic. The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 776-778.
[14] E. Panagiotou, P. Tsikouras, A. Bothou, S. Fotopoulos, S. Zervoudis, D. Deuteraiou, A.B. Chalil, G. Trypsianis, G. Galazios. A comparative study of the contribution of antenatal corticosteroids administration on improving neonatal respiratory function after elective cesarean section[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 368-374.
[15] L. Wang, N. Zhao, J. Zhou, M. Xu. Factors for predicting cesarean section during epidural analgesia: a retrospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 443-446.
No Suggested Reading articles found!